EULAV Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
EULAV Asset Management's NVO Position: Q3 2018 in Review
EULAV Asset Management sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 129,000 shares — an estimated $2.98M sold.
EULAV Asset Management first reported a position in NVO in Q2 2013 and held it in 21 quarters. The position peaked at $14.9M in Q2 2014. 557 funds tracked by Wall St. Rank hold NVO as of Q3 2018.
- EULAV Asset Management reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
- EULAV Asset Management sold 129,000 Novo Nordisk shares in Q3 2018, an estimated $2.98M.
- EULAV Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 21 quarters.
- EULAV Asset Management's Novo Nordisk position peaked at $14.9M in Q2 2014.
- 557 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.
Based on EULAV Asset Management's 13F filing for Q3 2018, filed 26 Oct 2018.